Search the hub
Showing results for tags 'Cancer'.
Found 545 results
-
Content ArticleProfessor Peter Brennan is a NHS Consultant Surgeon in Portsmouth, specialising in head and neck cancer. In this episode of the Human Factor Podcast, Peter discusses how he is driving Human Factors approaches from his perspective. To date, Peter has published over 700 publications including more than 80 on Human Factors and patient safety. His HF work has changed the delivery of postgraduate surgery exam delivery in the UK and abroad. Watch all the Human Factors Podcast episodes here.
-
Content ArticleThe government has published the first ever Women's Health Strategy for England to tackle the gender health gap.
-
Content ArticleThis article describes how a radiology group in Arizona allegedly missed dozens of breast malignancies, some of which were obviously cancer. Breast surgeon Dr Beth Dupree and a team of expert radiologists identified 25 missed cancer diagnoses that required either surgery, chemotherapy, radiation or a mastectomy at Northern Arizona Healthcare between 2016 and 2018. The team felt that there was a high chance of the number of women with missed cancers being higher than those uncovered by the review, but their request to expand the investigation did not go ahead.
-
Content ArticleCancer research is a crucial pillar for countries to deliver more affordable, higher quality, and more equitable cancer care. Patients treated in research-active hospitals have better outcomes than patients who are not treated in these settings. However, cancer in Europe is at a crossroads. Cancer was already a leading cause of premature death before the COVID-19 pandemic, and the disastrous effects of the pandemic on early diagnosis and treatment will probably set back cancer outcomes in Europe by almost a decade. Recognising the pivotal importance of research not just to mitigate the pandemic today, but to build better European cancer services and systems for patients tomorrow, the Lancet Oncology European Groundshot Commission on cancer research brings together a wide range of experts, together with detailed new data on cancer research activity across Europe during the past 12 years.
-
Content ArticleIn 2021-22 the House of Commons Health and Social Care Select Committee held an inquiry into Cancer services, asking for evidence of why cancer outcomes in England continue to lag behind comparable countries internationally and examine evidence relating to the underlying causes of these differences. This document was submitted by Pancreatic Cancer UK as part of the call for written evidence in this inquiry.
-
Content ArticleFor specialist treatment, Palestinians often need to be referred to a hospital outside Gaza – then apply for a travel permit. Tight budgets and restrictions mean few are granted. Int this Guardian article, one woman details the obstacles she has faced.
-
Content ArticlePancreatic cancer is the fifth most common cause of cancer death in the UK, with an annual incidence of nearly 9,600. On average, 23 people die each day from the disease. The UK has one of the worst survival rates in Europe, with average life expectancy on diagnosis just 4 to 6 months and a relative survival to 1 year of approximately 20%. Only 3% of people survive for 5 years or longer. This figure has not improved much in over 40 years, and it is not yet clear how the more recent trend of increased surgery and adjuvant chemotherapy will affect survival. There are often delays in access to diagnosis and treatment and this NICE guideline will help to improve this.
-
Content Article
Pancreatic Cancer UK: Real life stories section
Patient Safety Learning posted an article in Patient stories
These stories provide examples of how people with pancreatic cancer are diagnosed, the treatment they have, their experiences and how they take care of themselves. Everyone diagnosed with pancreatic cancer will be different in terms of how they received their diagnosis and how they respond to and cope with treatment. -
Content ArticleMr B was 71 years' old and was undergoing treatment for cancer of the oesophagus. During surgery, a nasogastric tube that had been inserted became dislodged and was put back into place by medical staff, despite guidelines against this. The family realised that something had gone wrong in the operation and Mr B became very seriously ill, dying five months later. When the family asked the hospital for an investigation, they revealed that a hole had been made in Mr B’s stomach when the nasogastric tube was replaced. There was no assurance given that steps would be taken to prevent similar errors in the future, and no apology from the hospital. The family sought legal advice and came to an out of court settlement with the hospital.
-
Content ArticleThis short video talks about the importance of recognising the signs and symptoms of head and neck cancer at the earliest opportunity, and describes actions which can be taken to support earlier diagnosis. Although aimed at pharmacists, it provides useful information for all patients and healthcare professionals on symptoms that might indicate head and neck cancer.
-
Content ArticlePatients with head and neck cancer may be required to travel significant distances for treatment, follow up and rehabilitation. This article in thr journal Cancer Nursing Practice presents findings from an evaluation of a pilot head and neck cancer service redesign in Thames Valley Cancer Alliance to enable patients from Swindon and Wiltshire to receive follow up and rehabilitation closer to home. The evaluation identified a decrease in overall outpatient visit time for these patients, resulting in reduced travel costs and improved quality of life.
-
Content ArticleWith A&E and ambulance waiting times dominating the headlines and over 6.7 million people waiting for elective surgery, prevention can unfortunately fall down the priority list. But cancer screening helps pick up cancers at an earlier and more treatable stage, improving survival rates and lessening pressure on the NHS in the long run. It is therefore important that it is not forgotten in the face of seemingly more urgent demands.
-
EventuntilNCRI Virtual Showcase will feature a number of topical sessions, panel discussions and proffered paper presentations covering the latest discoveries across: Big data and AI Prevention and early detection Immunology and immunotherapy Living with and beyond cancer Cancer research and COVID-19 Further information and registration
-
EventuntilHanan L'Estrange-Snowdon, Picker's Insight Manager, is hosting a discussion about the care experiences of people living with cancer. Hanan is joined by Chris Graham, Picker's CEO; Ruth Hendy, Lead Cancer Nurse at UHBW and Sue Kernaghan, Cancer Patient Representative. The conversation will cover: The Cancer Patient Experience Survey (CPES). How University Hospitals Bristol and Weston are working to improve patient care. How to effectively engage patient groups. This webinar will give you a deeper understanding of the CPES survey, enabling you to use the results more effectively. There will be insights into best practice to take back to your organisation and an understanding of how to engage with your patients. Register
-
Content ArticleDave Noakes talks about his cancer journey, the feelings he went through and the impact it has had on his life in this blog for Movember.
-
Content ArticleActive surveillance (AS) is an option in the management of men with low-stage, low-risk prostate cancer. These patients, who often require prolonged follow-up, can put a strain on outpatient resources. Nurses are ideally placed to develop advanced roles to help meet this increased demand—a model Martin et al. have utilised since 2014. The authors set about to comprehensively evaluate their nurse-led AS (NLAS) programme. The study found that nurse-led active surveillance is safe and effective. Patients and stakeholders alike held positive views of the programme.
-
Content Article
Movember: Testicular cancer
Patient Safety Learning posted an article in Men's health
At greater than 95%, the odds of survival for men with testicular cancer are better than good – but for some men, long-term treatment-related side effects, mean quality of life is severely compromised. This web pages focuses on getting these predominantly young men back to living full and healthy lives. -
Content Article
Prostate Cancer UK: Personalised stratified follow-up
Patient Safety Learning posted an article in Men's health
This cost-effective programme for personalised stratified follow-up delivers better outcomes for prostate cancer patients and has been shown to free up capacity in the follow-up pathway. The programme moves follow-up care from outpatient clinics to remote monitoring. Men who are eligible for remote follow up therefore don't need to attend routine appointments unless an issue arises. This web page gives advice, guidance and tools, and examples of hospital trusts that took part in the pilot. -
Content Article
Prostate Cancer UK: Best practice pathway
Patient Safety Learning posted an article in Men's health
Developed to support healthcare professionals at the front line of prostate cancer diagnosis and care, Prostate Cancer UK's Best Practice Pathway uses easy to follow flowcharts to guide healthcare professionals deliver best practice diagnosis, treatment and support. It sets out how to achieve an early diagnosis in men at higher than average risk of the disease. It also supports use of the most up-to-date, cutting-edge research-led innovations - so that healthcare professionals are equipped and supported to provide the very latest evidence-based best practice to their patients. -
Content ArticleJoin a new study to help us understand why black men are at higher risk of prostate cancer. Prostate Cancer UK are funding the PROFILE study to help find out why black men are at higher risk of prostate cancer than other ethnic groups. The researchers are looking at the genes of healthy men at higher risk of prostate cancer, including men of African or Caribbean descent. Over five years, they’ll monitor the men for signs of developing prostate cancer, using blood tests and scans and biopsies. At the end of the study, the researchers hope to understand why certain men are more likely to get prostate cancer, and whether one day they could create tests to help spot these men earlier, based on their genes. By working towards catching prostate cancer sooner in high risk men, we can increase the chances of curing their prostate cancer. And by understanding more about why and how they develop prostate cancer, we could work towards treatments that stop this from happening. If you are a man of African or Caribbean descent aged 40-69 and haven’t had prostate cancer, you may be suitable to take part in a study that can help us understand more about the genetics of prostate cancer. Follow the link below for further information.
-
Content Article
Prostate Cancer UK: risk checker
Patient Safety Learning posted an article in Men's health
Prostate cancer is the most common cancer in men, but most men with early prostate cancer don’t have symptoms. So what should you do? Click the link below and and answer three quick questions to find out. -
Content Article“Structural racism” refers to the ways in which historical and contemporary racial inequities in outcomes are perpetuated by social, economic, and political systems, including mutually reinforcing systems of health care, education, housing, employment, the media, and criminal justice. It results in systemic variation in opportunity according to race or ethnic background — for example, in racial differentials in access to health care. Ansell et al. use the case study of a 60-year-old Black woman with breast cancer as an example of structural racism and propose three critical strategies for addressing structural racism in health care. These strategies hinge on shifting the focus of work on racial differences in health outcomes from biologic or behavioural problems to the design of health care organisations and other social institutions.
-
Content ArticleWorldwide, cervical cancer is one of the leading causes of death from cancer in women. Cervical cancer accounts for 2% of all new cancer cases in females in the UK (Cancer Research UK 2016) and is, generally, a preventable disease. The primary cause of cervical abnormalities and cancer is persistent or chronic infection with one or more of the high-risk (oncogenic) types of human papillomavirus (HPV). In most women and men who become infected with HPV, these infections will resolve spontaneously (without treatment). However, for a minority of women, the infection leads to abnormal changes to the cervix, which, if not treated, may progress to cancer 10 to 20 years later. Both understanding and identifying HPV are important public health concerns and form part of the UK National Screening Programme.
-
Content ArticleAuthors of this study, published in Radiology, noted that mammography was more effective at finding breast cancer in high-risk men than in women at average risk of breast cancer. For every 1,000 mammograms done in high-risk men, 18 breast cancers were found. In comparison, five breast cancers are found for every 1,000 mammograms in average-risk women. They concluded that there is potential benefit in screening men at high risk for developing breast cancer.
-
Content ArticleIn March, the charity Breast Cancer Now asked people with breast cancer to tell us how coronavirus had affected their treatment and care. 580 people responded. Many reported that they or their loved ones had experienced delays or cancellations to treatment and monitoring scans. Others had not experienced any changes to their treatment. To understand how people’s experiences may have changed and try to better quantify some of the impacts, Breast Cancer Now ran a second survey between 9 July and 6 August. 2,124 people with breast cancer responded. They also spoke to 12 healthcare professionals from different parts of the breast cancer pathway including radiographers, surgeons, oncologists specialising in drug treatment and radiotherapy, and clinical nurse specialists. This was supplemented by data available on the impact of the pandemic, for example on referrals to see a specialist. This report sets out their findings and recommendations for what needs to happen next to tackle the challenges identified. The content is split into four sections: Diagnosis Treatment Clinical trials and research Care and support.
